Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression
View ORCID ProfileYuri Milaneschi, Matthias Arnold, Gabi Kastenmüller, Siamak Mahmoudian Dehkordi, Ranga R. Krishnan, Boadie W. Dunlop, A. John Rush, Brenda W. J. H. Penninx, Rima Kaddurah-Daouk, for the Mood Disorders Precision Medicine Consortium (MDPMC)
doi: https://doi.org/10.1101/2021.10.18.21265157
Yuri Milaneschi
1Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, The Netherlands
Matthias Arnold
2Institute of Computational Biology, Helmholtz Zentrum München – German Research Center for Environmental Health, Neuherberg, Germany
3Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
Gabi Kastenmüller
2Institute of Computational Biology, Helmholtz Zentrum München – German Research Center for Environmental Health, Neuherberg, Germany
4German Center for Diabetes Research (DZD), Neuherberg, Germany
Siamak Mahmoudian Dehkordi
3Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
Ranga R. Krishnan
5Department of Psychiatry, Rush Medical College, Chicago, IL, USA
Boadie W. Dunlop
6Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
A. John Rush
3Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
7Duke-National University of Singapore, Singapore
8Department of Psychiatry, Texas Tech University, Health Sciences Center, Permian Basin, TX USA
Brenda W. J. H. Penninx
1Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, The Netherlands
Rima Kaddurah-Daouk
3Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
9Duke Institute of Brain Sciences, Duke University, Durham, USA
10Department of Medicine, Duke University, Durham, USA
Article usage
Posted October 19, 2021.
Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression
Yuri Milaneschi, Matthias Arnold, Gabi Kastenmüller, Siamak Mahmoudian Dehkordi, Ranga R. Krishnan, Boadie W. Dunlop, A. John Rush, Brenda W. J. H. Penninx, Rima Kaddurah-Daouk, for the Mood Disorders Precision Medicine Consortium (MDPMC)
medRxiv 2021.10.18.21265157; doi: https://doi.org/10.1101/2021.10.18.21265157
Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression
Yuri Milaneschi, Matthias Arnold, Gabi Kastenmüller, Siamak Mahmoudian Dehkordi, Ranga R. Krishnan, Boadie W. Dunlop, A. John Rush, Brenda W. J. H. Penninx, Rima Kaddurah-Daouk, for the Mood Disorders Precision Medicine Consortium (MDPMC)
medRxiv 2021.10.18.21265157; doi: https://doi.org/10.1101/2021.10.18.21265157
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12531)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4409)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2838)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4167)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6752)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)